Compare MXC & COCH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
| Metric | MXC | COCH |
|---|---|---|
| Founded | 1972 | 1995 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Oil & Gas Production | Blank Checks |
| Sector | Energy | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 18.4M | 20.4M |
| IPO Year | N/A | N/A |
| Metric | MXC | COCH |
|---|---|---|
| Price | $8.93 | $0.84 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 1 |
| Target Price | N/A | ★ $9.50 |
| AVG Volume (30 Days) | 3.6K | ★ 541.8K |
| Earning Date | 11-12-2025 | 11-10-2025 |
| Dividend Yield | ★ 1.12% | N/A |
| EPS Growth | ★ 39.24 | N/A |
| EPS | ★ 0.79 | N/A |
| Revenue | ★ $7,429,923.00 | $208,000.00 |
| Revenue This Year | N/A | $3.66 |
| Revenue Next Year | N/A | $31.19 |
| P/E Ratio | $11.26 | ★ N/A |
| Revenue Growth | ★ 7.26 | N/A |
| 52 Week Low | $5.89 | $0.64 |
| 52 Week High | $16.00 | $2.32 |
| Indicator | MXC | COCH |
|---|---|---|
| Relative Strength Index (RSI) | 47.99 | 56.44 |
| Support Level | $8.50 | $0.66 |
| Resistance Level | $9.48 | $0.87 |
| Average True Range (ATR) | 0.36 | 0.07 |
| MACD | -0.04 | 0.02 |
| Stochastic Oscillator | 35.83 | 86.84 |
Mexco Energy Corporation is an independent oil and gas company. It is engaged in the acquisition, exploration, development, and production of natural gas and crude oil properties located in the United States. The company carried out its operation in the Permian Basin of West Texas. It is focusing on two primary areas, the Delaware Basin located in the Western portion of the Permian Basin including Lea and Eddy Counties, New Mexico and Loving County, Texas, and the Midland Basin located in the Eastern portion of the Permian Basin including Reagan, Upton, Midland, Martin, Howard, and Glasscock Counties, Texas. The company generates revenue from Oil sales, Natural gas sales, oil and gas royalty interests.
Envoy Medical Inc is a hearing health company focused on providing medical technologies. It is dedicated to pushing hearing technology beyond the status quo to provide patients with improved access, usability, independence and quality of life. The Company has one reportable segment: hearing. The hearing segment derives revenue from the sale of the Esteem FI-AMEI implants and replacement components to Esteem FI-AMEI implants.